ETRM - ReShape Lifesciences Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 529.86M
Enterprise Value 35.39M
Trailing P/E N/A
Forward P/E 1-3.20
PEG Ratio (5 yr expected) 1-5.88
Price/Sales (ttm)52.22
Price/Book (mrq)0.45
Enterprise Value/Revenue 39.43
Enterprise Value/EBITDA 6-0.24

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Jun 30, 2017

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-3,896.15%

Management Effectiveness

Return on Assets (ttm)-48.42%
Return on Equity (ttm)-146.32%

Income Statement

Revenue (ttm)571.76k
Revenue Per Share (ttm)0.15
Quarterly Revenue Growth (yoy)-66.30%
Gross Profit (ttm)N/A
EBITDA -22.15M
Net Income Avi to Common (ttm)-25.16M
Diluted EPS (ttm)-6.50
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)11.2M
Total Cash Per Share (mrq)1.35
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.94
Book Value Per Share (mrq)4.58

Cash Flow Statement

Operating Cash Flow (ttm)-18.25M
Levered Free Cash Flow (ttm)-9.67M

Trading Information

Stock Price History

Beta 2.56
52-Week Change 33,860.00%
S&P500 52-Week Change 317.21%
52 Week High 330.41
52 Week Low 30.04
50-Day Moving Average 31.94
200-Day Moving Average 33.35

Share Statistics

Avg Vol (3 month) 31.56M
Avg Vol (10 day) 31.06M
Shares Outstanding 514.57M
Float 7.73M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 31.13M
Short Ratio 35.33
Short % of Float 316.31%
Shares Short (prior month) 3943.54k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/70
Last Split Date 3Dec 28, 2016